Position in EYPT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$4,942,579
-$2,659,566 QoQ
Shares Held
383,443
-7.8% QoQ
Ownership
0.457%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$409,047
PutShares
17,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. EYPT ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,942,579 | 383,443 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $7,602,145 | 416,100 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,387,112 | 1,010,331 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $7,661,179 | 814,153 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,066,147 | 750,212 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,827,822 | 648,030 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,018,689 | 502,965 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,505,902 | 288,035 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,625,599 | 175,404 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,812,840 | 78,444 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $409,047 | 17,700 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $60,403 | 7,560 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $56,270 | 6,468 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $983,024 | 334,362 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,185,086 | 338,596 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $78,632 | 9,941 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,336 | 8,302 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $105,570 | 8,689 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $927,791 | 75,800 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $123,143 | 11,818 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $51,188 | 5,694 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $69,088 | 6,800 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||